Reliability note

Titles and AI summaries are unofficial English monitoring aids, not legal advice or official translations. Each link opens the original Japanese official source, which remains authoritative.

Japan Healthcare & Pharmaceutical Regulation Updates

Official Japanese developments on pharmaceuticals, medical devices, drug safety information, and healthcare administration, monitored daily from government, regulator, Diet, and self-regulatory sources and labelled in English for triage. Area labels are assigned by keyword rules for triage, so this page may miss relevant items or include marginal ones.

417 updates tracked · 417 with AI summaries · 11 open public comments · last checked 2026-11-21

Search and filter this area in the dashboard RSS feed Deadline calendar (.ics)

Open public comments

Consultations still accepting comments, soonest deadline first. Confirm the deadline and submission method in the official source.

  1. Draft Ministerial Ordinance Amending Pharmaceutical and Medical Device Enforcement Regulations 2026-10-28 · e-Gov Public Comment · Public Comment Open Comments due: 2026-11-26 23:59 JST Original Japanese source

    A draft Ministerial Ordinance to partially amend the Regulation for Enforcement of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices was published for public comment on 2026-10-28. The stated comment deadline is 2026-11-26 23:59 JST, and the listed contact is… (AI summary)

  2. Draft Ministerial Ordinance Amending Rules on Integrated Regional Medical and Long-Term Care 2026-10-27 · e-Gov Public Comment · Public Comment Open Comments due: 2026-11-26 18:00 JST Original Japanese source

    A draft ministerial ordinance to partially amend the Enforcement Regulations of the Act on Promotion of Comprehensive Securing of Medical and Long-Term Care in Communities was published for public comment on 2026-10-27. The stated comment deadline is 2026-11-26 18:00 JST; the listed responsible office is the Medical… (AI summary)

  3. Draft amendment to designated medicines and periods under pharmaceutical regulations 2026-10-30 · e-Gov Public Comment · Public Comment Open Comments due: 2026-11-29 00:00 JST Original Japanese source

    A draft amendment to the medicines and periods designated by the Minister of Health, Labour and Welfare under Article 216-2, paragraph 1 of the Enforcement Regulations of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices was published for public comment on… (AI summary)

  4. Public Comment: Draft Revision of Japanese Industrial Standards for Medical Devices 2026-09-29 · e-Gov Public Comment · Public Comment Open Comments due: 2026-11-28 23:59 JST Original Japanese source

    The Japanese government has opened a public comment period on a draft revision of Japanese Industrial Standards (JIS) relating to medical devices. The draft was announced on 2026-09-29, and comments are accepted until 2026-11-28 23:59. The listed contact is the Medical Device Evaluation Division, Pharmaceutical… (AI summary)

  5. Draft Cabinet Order amending the enforcement order on regenerative medicine safety 2026-11-06 · e-Gov Public Comment · Public Comment Open Comments due: 2026-12-05 00:00 JST Original Japanese source

    A draft Cabinet Order would amend the Enforcement Order of the Act on Ensuring the Safety of Regenerative Medicine. The draft was published for public comment on 2026-11-06, with a stated deadline of 2026-12-05 00:00 JST; the listed contact is the Research and Development Policy Division, Medical Affairs Bureau… (AI summary)

  6. Draft Ministerial Ordinance Amending the Regulation for Enforcement of the Medical Care Act 2026-11-09 · e-Gov Public Comment · Public Comment Open Comments due: 2026-12-08 00:00 JST Original Japanese source

    A draft Ministerial Ordinance partially amending the Regulation for Enforcement of the Medical Care Act was published for public comment on 2026-11-09. The stated comment deadline is 2026-12-08 00:00 JST. The responsible office is the Research and Development Policy Division, Medical Policy Bureau, Ministry of… (AI summary)

  7. Draft designation of pharmaceuticals under Article 80 of the Pharmaceuticals Act Enforcement Order 2026-11-10 · e-Gov Public Comment · Public Comment Open Comments due: 2026-12-09 23:59 JST Original Japanese source

    The Ministry of Health, Labour and Welfare published a draft designation of pharmaceuticals for public comment on 2026-11-10. The proposed designation is by the Minister under Article 80, paragraph 2, item 7(f) of the Enforcement Order of the Act on Securing Quality, Efficacy and Safety of Products Including… (AI summary)

  8. Draft Cabinet Order amending the enforcement order on medical care for older persons 2026-11-16 · e-Gov Public Comment · Public Comment Open Comments due: 2026-12-16 00:00 JST Original Japanese source

    The Ministry of Health, Labour and Welfare published a draft Cabinet Order for public comment on 2026-11-16 to partially amend the Enforcement Order of the Act on Assurance of Medical Care for Elderly People. The stated comment deadline is 2026-12-16 00:00 JST. The listing does not describe the proposed amendments or… (AI summary)

  9. Draft Cabinet Order Amending the Order for Enforcement of the Medical Care Act and Other Orders 2026-11-16 · e-Gov Public Comment · Public Comment Open Comments due: 2026-12-16 17:00 JST Original Japanese source

    A draft Cabinet Order to partially amend the Order for Enforcement of the Medical Care Act and other orders was published for public comment on 2026-11-16. The stated comment deadline is 2026-12-16 17:00 JST. The responsible contact is the Regional Medical Care Planning Division, Medical Policy Bureau, Ministry of… (AI summary)

  10. Draft Ministerial Ordinance Amending Rules on Integrated Community Medical and Long-Term Care 2026-11-19 · e-Gov Public Comment · Public Comment Open Comments due: 2026-12-18 23:59 JST Original Japanese source

    A draft ministerial ordinance would amend the Enforcement Regulations of the Act on Promoting the Comprehensive Securing of Medical and Long-Term Care in Communities. The draft was published for public comment on 2026-11-19, with a stated deadline of 2026-12-18 23:59 JST. The listed contact is the Office of the… (AI summary)

  11. Draft amendment to designated medical devices and ministerial standards 2026-11-19 · e-Gov Public Comment · Public Comment Open Comments due: 2026-12-19 23:59 JST Original Japanese source

    The Ministry of Health, Labour and Welfare published a draft amendment for public comment on 2026-11-19 concerning medical devices designated under Article 23-2-23(1) of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. The draft would amend the existing… (AI summary)

Latest updates

Newest official publications first.

  1. PMDA announces web survey on essential-edition medicine and vaccine guides 2026-11-20 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-11-20, the Pharmaceuticals and Medical Devices Agency (PMDA) announced a web survey about its essential-edition guides for patients using medicines and people receiving vaccines. These guides, first provided in late April 2026, summarize information particularly important when using medicines or vaccines; the… (AI summary)

  2. Draft Ministerial Ordinance Amending Rules on Integrated Community Medical and Long-Term Care 2026-11-19 · e-Gov Public Comment · Public Comment Open Original Japanese source

    A draft ministerial ordinance would amend the Enforcement Regulations of the Act on Promoting the Comprehensive Securing of Medical and Long-Term Care in Communities. The draft was published for public comment on 2026-11-19, with a stated deadline of 2026-12-18 23:59 JST. The listed contact is the Office of the… (AI summary)

  3. Draft amendment to designated medical devices and ministerial standards 2026-11-19 · e-Gov Public Comment · Public Comment Open Original Japanese source

    The Ministry of Health, Labour and Welfare published a draft amendment for public comment on 2026-11-19 concerning medical devices designated under Article 23-2-23(1) of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. The draft would amend the existing… (AI summary)

  4. Emergency order suspends specified regenerative medicine at ICVS Tokyo Clinic 2026-11-19 · Ministry of Health, Labour and Welfare (MHLW) · Government Announcement Original Japanese source

    On 2026-11-19, the Ministry of Health, Labour and Welfare announced an emergency order under Article 22 of the Act on the Safety of Regenerative Medicine (Act No. 85 of 2013) against Medical Corporation ICVS Tokyo Clinic in Chiyoda City, Tokyo. The order required temporary suspension, among other measures, of… (AI summary)

  5. MHLW announcement: unauthorized access and possible pharmaceutical system data leak 2026-11-18 · Ministry of Health, Labour and Welfare (MHLW) · Government Announcement Original Japanese source

    On 2026-11-18, the Ministry of Health, Labour and Welfare announced unauthorized access to its pharmaceutical stable supply and distribution verification system. It identified evidence that some stored data had been viewed and attempts made to alter viewed data, with possible leakage of names and contact details of… (AI summary)

  6. Class I recall: Irradiated Red Blood Cells-LR "Nisseki" and one other item 2026-11-18 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    A PMDA safety listing dated 2026-11-18 identifies a Class I recall covering Irradiated Red Blood Cells-LR "Nisseki" and one other item. The provided title does not identify the other item, affected lots, reason for recall, or recall procedures. (AI summary)

  7. Draft Cabinet Order amending the enforcement order on medical care for older persons 2026-11-16 · e-Gov Public Comment · Public Comment Open Original Japanese source

    The Ministry of Health, Labour and Welfare published a draft Cabinet Order for public comment on 2026-11-16 to partially amend the Enforcement Order of the Act on Assurance of Medical Care for Elderly People. The stated comment deadline is 2026-12-16 00:00 JST. The listing does not describe the proposed amendments or… (AI summary)

  8. Draft Cabinet Order Amending the Order for Enforcement of the Medical Care Act and Other Orders 2026-11-16 · e-Gov Public Comment · Public Comment Open Original Japanese source

    A draft Cabinet Order to partially amend the Order for Enforcement of the Medical Care Act and other orders was published for public comment on 2026-11-16. The stated comment deadline is 2026-12-16 17:00 JST. The responsible contact is the Regional Medical Care Planning Division, Medical Policy Bureau, Ministry of… (AI summary)

  9. Notice amendment on reporting suspected adverse reactions after routine and temporary vaccinations 2026-11-16 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    The official page explains that physicians and other reporting professionals must report specified symptoms following routine or temporary vaccinations to the Ministry of Health, Labour and Welfare under Article 12(1) of the Immunization Act; duplicate reporting under the pharmaceuticals and medical devices… (AI summary)

  10. PMDA adds patient-reported adverse reaction reports received April–July 2026 2026-11-16 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-11-16, the Pharmaceuticals and Medical Devices Agency (PMDA) announced the addition of patient adverse reaction reports received from 2026-04-01 through 2026-07-31. The page publishes reports from patients or their families, excluding personal information, in case-based and medicine-based lists; its coverage… (AI summary)

  11. PMDA announces darolutamide and trastuzumab package-insert revisions 2026-11-16 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-11-16, the Pharmaceuticals and Medical Devices Agency (PMDA) published consultation-based package-insert revisions for Bayer's Nubeqa tablets 300 mg (darolutamide) and Pfizer's trastuzumab BS intravenous infusion products 60 mg and 150 mg. For darolutamide, Section 7 adds a reference to the electronic package… (AI summary)

  12. PMDA announces Rybelsus package-insert revision adding cardiovascular trial results 2026-11-13 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-11-13, the Pharmaceuticals and Medical Devices Agency (PMDA) listed a consultation-based package-insert revision for Novo Nordisk Pharma Ltd.'s Rybelsus tablets, 3 mg, 7 mg and 14 mg (semaglutide, recombinant). The supporting document dated 2026-07-15 describes adding results from trial EX9924-4473 as new… (AI summary)

  13. PMDA announcement: FY2026 patient-reported suspected adverse drug reactions 2026-11-11 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    The Pharmaceuticals and Medical Devices Agency (PMDA) published FY2026 patient adverse-reaction report information on 2026-11-11, including drug-specific tables for April through July 2026. The page links separate tables for prescription medicines and nonprescription medicines, including medicines requiring… (AI summary)

  14. Draft designation of pharmaceuticals under Article 80 of the Pharmaceuticals Act Enforcement Order 2026-11-10 · e-Gov Public Comment · Public Comment Open Original Japanese source

    The Ministry of Health, Labour and Welfare published a draft designation of pharmaceuticals for public comment on 2026-11-10. The proposed designation is by the Minister under Article 80, paragraph 2, item 7(f) of the Enforcement Order of the Act on Securing Quality, Efficacy and Safety of Products Including… (AI summary)

  15. PMDA announcement: nitrosamine detection in sertraline and telmisartan tablets 2026-11-10 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-11-10, the Pharmaceuticals and Medical Devices Agency (PMDA) announced publication of nitrosamine-detection notices for sertraline and telmisartan tablets. The linked page lists sertraline 25 mg and 50 mg tablets labeled Towa, and telmisartan 20 mg, 40 mg and 80 mg tablets labeled Felzen, Sandoz and Meiji.… (AI summary)

  16. Draft Ministerial Ordinance Amending the Regulation for Enforcement of the Medical Care Act 2026-11-09 · e-Gov Public Comment · Public Comment Open Original Japanese source

    A draft Ministerial Ordinance partially amending the Regulation for Enforcement of the Medical Care Act was published for public comment on 2026-11-09. The stated comment deadline is 2026-12-08 00:00 JST. The responsible office is the Research and Development Policy Division, Medical Policy Bureau, Ministry of… (AI summary)

  17. Class I Recall: Irradiated Red Blood Cells-LR "Nisseki" 2026-11-09 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    A PMDA safety listing dated 2026-11-09 identifies Irradiated Red Blood Cells-LR "Nisseki" as a product subject to a Class I recall. The provided title does not specify the recall reason, affected lots, distribution scope, or handling instructions. (AI summary)

  18. Draft Cabinet Order amending the enforcement order on regenerative medicine safety 2026-11-06 · e-Gov Public Comment · Public Comment Open Original Japanese source

    A draft Cabinet Order would amend the Enforcement Order of the Act on Ensuring the Safety of Regenerative Medicine. The draft was published for public comment on 2026-11-06, with a stated deadline of 2026-12-05 00:00 JST; the listed contact is the Research and Development Policy Division, Medical Affairs Bureau… (AI summary)

  19. Class I recall: ARROW PIC Catheter Kit HP 2026-11-06 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    A Pharmaceuticals and Medical Devices Agency (PMDA) safety listing dated 2026-11-06 identifies ARROW PIC Catheter Kit HP as a product subject to a Class I recall. The supplied title does not specify the recall reason, affected lots or recall instructions. (AI summary)

  20. Class I voluntary recall announcement: ARROW PIC Catheter Kit HP 2026-11-06 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-11-06, the Pharmaceuticals and Medical Devices Agency (PMDA) listed a Ministry of Health, Labour and Welfare announcement concerning a Class I voluntary recall of ARROW PIC Catheter Kit HP. The provided listing identifies the product and recall classification but does not state the reason for recall, affected… (AI summary)

  21. PMDA announcement: medical societies' documents on avacopan use 2026-11-05 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    PMDA's safety listing identifies an administrative communication dated 2026-11-04 requesting dissemination of documents published by relevant medical societies on the use of avacopan preparations. The listing confirms the documents' publication but does not describe their clinical recommendations or establish a new… (AI summary)

  22. PMDA announcement on nitrosamine detection in telmisartan products 2026-11-05 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-11-05, the Pharmaceuticals and Medical Devices Agency announced the posting of information on nitrosamine compounds detected in telmisartan products. The supplied page lists detection notices for telmisartan tablets in 20 mg, 40 mg and 80 mg strengths under the Fersen, Sandoz and Meiji names; the excerpts do… (AI summary)

  23. Draft amendment to designated medicines and periods under pharmaceutical regulations 2026-10-30 · e-Gov Public Comment · Public Comment Open Original Japanese source

    A draft amendment to the medicines and periods designated by the Minister of Health, Labour and Welfare under Article 216-2, paragraph 1 of the Enforcement Regulations of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices was published for public comment on… (AI summary)

  24. PMDA announcement on proper use of GLP-1 and GIP/GLP-1 receptor agonists 2026-10-30 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-10-30, the Pharmaceuticals and Medical Devices Agency (PMDA) announced the posting of a request concerning the proper use of GLP-1 receptor agonists and GIP/GLP-1 receptor agonists. The item was added to PMDA's requests for proper use of medicines. (AI summary)

  25. PMDA announcement: caution against confusing Fungizone and AmBisome 2026-10-30 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-10-30, the Pharmaceuticals and Medical Devices Agency (PMDA) announced that it had posted a notice cautioning against confusing Fungizone and AmBisome. The notice was listed under pharmaceutical companies' information on the safe use of medicines. (AI summary)

  26. Class I recall: Fresh Frozen Plasma-LR "Nisseki" 480 2026-10-29 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    A PMDA safety update published on 2026-10-29 lists a Class I recall of Fresh Frozen Plasma-LR "Nisseki" 480. The supplied title does not specify the reason for recall or the affected lots. (AI summary)

  27. Draft Ministerial Ordinance Amending Pharmaceutical and Medical Device Enforcement Regulations 2026-10-28 · e-Gov Public Comment · Public Comment Open Original Japanese source

    A draft Ministerial Ordinance to partially amend the Regulation for Enforcement of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices was published for public comment on 2026-10-28. The stated comment deadline is 2026-11-26 23:59 JST, and the listed contact is… (AI summary)

  28. PMDA notice: Nitrosamine detection in Rizatriptan OD Tablets 10 mg "TCK" 2026-10-28 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-10-28, the Pharmaceuticals and Medical Devices Agency (PMDA) announced that it had posted a notice concerning detection of a nitrosamine compound in Rizatriptan OD Tablets 10 mg "TCK". The supplied title does not specify the detected level, affected batches, or any recall or other response. (AI summary)

  29. PMDA announcement: Warning Report No. 7 on preventing medical accident recurrence 2026-10-28 · Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Government Announcement Original Japanese source

    On 2026-10-28, the Pharmaceuticals and Medical Devices Agency (PMDA) posted an announcement concerning publication of Warning Report No. 7 on preventing the recurrence of medical accidents. The title does not identify the accidents or preventive measures covered. (AI summary)

  30. Draft Ministerial Ordinance Amending Rules on Integrated Regional Medical and Long-Term Care 2026-10-27 · e-Gov Public Comment · Public Comment Open Original Japanese source

    A draft ministerial ordinance to partially amend the Enforcement Regulations of the Act on Promotion of Comprehensive Securing of Medical and Long-Term Care in Communities was published for public comment on 2026-10-27. The stated comment deadline is 2026-11-26 18:00 JST; the listed responsible office is the Medical… (AI summary)

Most frequent sources in this area